✓ Η πληρωμή με πιστωτική κάρτα αποκαταστάθηκε — ασφαλής ολοκλήρωση αγοράς μέσω Privacy Shield

Daruvir

Daruvir (Darunavir 600 mg) — Cipla second-generation protease inhibitor with high genetic barrier to resistance. Always ritonavir-boosted. Preferred PI for treatment-experienced HIV.

Ιατρικά ελεγμένο από Morgan Ellis — Ερευνητής Φαρμακευτικής · 8 χρόνια εμπειρία  · Τελευταία αναθεώρηση: Μάιος 2026

Κρυπτογραφημένη αγορά
Η πληρωμή με κρυπτονομίσματα κοστίζει 10% λιγότερο
Διακριτική παγκόσμια αποστολή
1,400+ πελάτες · 50+ χώρες

Αυτό το προϊόν είναι προσωρινά εξαντλημένο και μη διαθέσιμο.

Γρήγορη απάντηση

Daruvir — Darunavir 600 mg (Cipla Inc). Second-generation protease inhibitor. Boosted with ritonavir 100 mg BID or 800 mg + ritonavir 100 mg once daily. High genetic barrier — preferred PI in resistant disease.

Αυτό που λαμβάνετε με την MedsBase:

  • πιστοποιημένο από τη WHO-GMP κατασκευαστή
  • Discreet plain-envelope packaging
  • Παγκόσμια αποστολή
  • Rated by 1,400+ customers (read reviews)

📦 Reshipment Assurance: if your order has not arrived 20 business days after dispatch, we reship it at no extra cost. Read the policy.

Γιατί να παραγγείλετε από τη MedsBase

Daruvir ships from a WHO-GMP certified manufacturer in plain packaging, billed through a regulated payment processor (the statement descriptor reads a regulated card-payment processor — never MedsBase or any medication name). Every order carries our 20-business-day Reshipment Assurance.

Adherence and resistance
PIs have a relatively higher genetic barrier to resistance than NNRTIs but still require >95% adherence. Always combined with two NRTIs (typically TDF/FTC or ABC/3TC) for a complete regimen. PI/r refers to ritonavir-boosted PI — ritonavir is given at low dose (100 mg) as a CYP3A4 inhibitor to raise the levels of the partner PI.

How protease inhibitors work

HIV protease cleaves the gag-pol polyprotein into mature, functional viral proteins. Without protease, HIV produces immature non-infectious virions. PIs bind the protease active site and block cleavage.

Modern PI therapy almost always uses ritonavir or cobicistat as a pharmacokinetic booster — these CYP3A4 inhibitors raise levels of the partner PI (atazanavir, darunavir, lopinavir) and allow once-daily dosing.

Class-specific side effects

  • GI: diarrhoea, nausea, abdominal pain (especially lopinavir/r — most diarrhoea-prone)
  • Metabolic: dyslipidaemia, insulin resistance, lipodystrophy (less prominent with newer PIs darunavir, atazanavir than older lopinavir)
  • Ηπατικές: liver enzyme rises; caution in HBV/HCV co-infection
  • Cardiovascular: small association with MI risk (older PIs); newer PIs less affected
  • Atazanavir-specific: reversible indirect hyperbilirubinaemia (Gilbert-like jaundice — cosmetic, not hepatotoxic), nephrolithiasis, cholelithiasis
  • Darunavir-specific: rash (sulfa-related), hepatitis

Important drug interactions

  • Strong CYP3A4 substrates with narrow therapeutic index — absolute contraindications: simvastatin, lovastatin (use pravastatin/fluvastatin/pitavastatin instead); ergot alkaloids; pimozide; midazolam/triazolam (oral); rifampicin; St John’s wort; cisapride.
  • PPIs: reduce atazanavir absorption — separate by ≥12 hours OR avoid. Less issue with darunavir, lopinavir.
  • Rifampicin: drops PI levels >75% — use rifabutin instead, with PI dose adjustment.
  • Hormonal contraception: some PIs reduce ethinyl estradiol — use barrier contraception or alternative.
  • Anti-HCV DAAs: always check current Liverpool HIV-DDI database before combining HIV + HCV therapy.

Συχνές Ερωτήσεις

Why is ritonavir used as a booster?

Ritonavir at low dose (100 mg) inhibits CYP3A4, raising levels of the partner PI (atazanavir, darunavir, lopinavir). This allows once-daily dosing and lower pill burden. Cobicistat is an alternative booster (no antiviral activity, just CYP inhibition).

Will the regimen cure HIV?

No — ART suppresses viral replication for life. Stopping ART allows viral rebound within weeks. With consistent therapy and undetectable viral load, life expectancy approaches that of HIV-negative peers (U=U).

Τι γίνεται αν χάσω μια δόση;

Take it when you remember if <6 hours late. If >6 hours late, skip and resume normal schedule — do not double up. Repeated missed doses risk resistance development.

Side effects management?

Diarrhoea is the most common — usually settles within 4-6 weeks; can use loperamide. Lipid changes may need a statin (avoid simvastatin/lovastatin — use atorvastatin low-dose, rosuvastatin, or pitavastatin). Atazanavir jaundice is cosmetic and not hepatotoxic — no need to switch.

When should I take it?

Most boosted PIs are taken with food (improves absorption and tolerability). Atazanavir/r needs an acidic stomach — avoid PPIs; H2 blockers OK with timing separation. Darunavir/r and lopinavir/r are less pH-sensitive.

Drug interactions?

Major class — always disclose all medications. PIs are strong CYP3A4 inhibitors. Statins, rifampicin, ergotamines, oral contraceptives, anticonvulsants, antifungals, and many psychiatric drugs need adjustment or substitution. Use Liverpool HIV-DDI database (hiv-druginteractions.org).

HBV co-infection?

PI-based regimens do not treat HBV. The NRTI backbone (TDF + FTC or 3TC) treats both HIV and HBV — keep this combination if HBV co-infected. Stopping abruptly can flare HBV.

Pregnancy?

Atazanavir/r and darunavir/r have the most pregnancy data and are commonly used. Lopinavir/r is also acceptable. Cobicistat-boosted PIs are generally avoided in pregnancy due to reduced levels in 2nd/3rd trimester.

When are PIs preferred?

PIs are second-line under modern guidelines (integrase inhibitors are first-line). PIs remain useful for: pre-treated patients with INSTI resistance, patients with CNS disease (CSF penetration variable but useful), HIV-2 (where INSTIs work but resistance pathways differ), and pregnancy in some settings.

What about cardiovascular risk?

Older PIs (lopinavir, indinavir) carry small absolute MI excess. Newer PIs (atazanavir, darunavir) less so. Manage traditional CV risk factors (smoking, BP, lipids, weight, exercise) — these dominate over modest PI effect.

Other HIV & Antiviral Medications

  • Trioday — TDF + 3TC + EFV — single-tablet regimen by Cipla
  • Triomune — d4T + 3TC + NVP — older 3-in-1 (stavudine-based)
  • Zepdon — raltegravir 400 mg — integrase inhibitor
  • Abamune L — abacavir + lamivudine — alternative NRTI backbone
  • Tenvir L — tenofovir + lamivudine — alternative NRTI backbone
Ιατρική Αποποίηση Ευθυνών: HIV treatment is a complex, lifelong therapy. Drug choice depends on genotype, resistance testing, comorbidities, and prior treatment history. Discuss any regimen change with an HIV specialist. Adherence >95% is required to prevent resistance. Test for HBV before starting any tenofovir-, lamivudine-, or emtricitabine-containing regimen — withdrawal can cause severe HBV flare in co-infected patients.

More options in HIV Medication

Ταξινομημένα σύμφωνα με τον όγκο παραγγελιών στο MedsBase — τι επιλέγουν άλλοι πελάτες σε αυτήν την κατηγορία.

Ισχύς

600 mg

Ποσότητα

60 Tablet/s, 120 Tablet/s, 180 Tablet/s

Φαρμακευτική Μορφή

Δισκία

Κατασκευαστής

Cipla Inc

Θεραπεία

HIV Infection

Γενόσημη μάρκα

Darunavir

Κριτικές

Δεν υπάρχουν ακόμη κριτικές

Προσθήκη κριτικής
Daruvir Daruvir
Αξιολόγηση*
0/5
* Η αξιολόγηση είναι υποχρεωτική
* Η απάντηση είναι υποχρεωτική
Η κριτική σας
* Η κριτική είναι υποχρεωτική
Όνομα
* Απαιτείται όνομα
Προσθέστε φωτογραφίες ή βίντεο στην κριτική σας

Ερωτήσεις & Απαντήσεις

Κάντε μια ερώτηση
Daruvir Daruvir
Η ερώτησή σας
* Απαιτείται ερώτηση
Όνομα
* Απαιτείται όνομα
Δεν υπάρχουν ακόμα ερωτήσεις